Thermosensitive injectable hydrogels from poly(N-isopropylacrylamide)–dextran aqueous solutions: Thermogelation and drug release properties
Source abstract
Abstract
Novel injectable thermosensitive hydrogel formulations with improved both water retention (WR) and drug release profile were prepared by adding dextran (DXT) to poly(N-isopropylacrylamide) (PNIPAM) aqueous solutions as a remedy against the demixing/syneresis phenomenon. The addition of the hydrophilic polysaccharide improved the WR of the hydrogel at 37°C from about 12% in the absence of DXT to about 40–55% out of the initial amount introduced, depending on both PNIPAM and DXT concentrations. Also, the 5-fluorouracil release experiments showed an appreciably reduced “burst effect” for the DXT-containing hydrogels. The shape of the release profiles revealed the presence of two stages, differing each other from the point of view of the drug release rate.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems · Advanced Materials and Mechanics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioresources and Polymer Science, Faculty of Applied Chemistry and Materials Science, Polytechnic University of Bucharest, Bucharest, Romania
Funding
The Ministry of National Education, CNCS – UEFISCDI
References (42)
Show source-provided references
1. 10.1016/j.ejpb.2004.03.01910.1016/j.ejpb.2004.03.019 ↗
2. 10.1016/j.ijpharm.2008.01.05710.1016/j.ijpharm.2008.01.057 ↗
3. 10.1517/17425247.2011.58165610.1517/17425247.2011.581656 ↗
4. 10.1021/ma201261m10.1021/ma201261m ↗
5. 10.1002/polb.2308110.1002/polb.23081 ↗
6. 10.1016/j.progpolymsci.2012.08.00210.1016/j.progpolymsci.2012.08.002 ↗
7. 10.1016/j.progpolymsci.2014.07.00610.1016/j.progpolymsci.2014.07.006 ↗
8. 10.1016/j.msec.2014.04.02610.1016/j.msec.2014.04.026 ↗
9. 10.1016/j.jconrel.2014.04.05610.1016/j.jconrel.2014.04.056 ↗
10. 10.1166/jbn.2015.196210.1166/jbn.2015.1962 ↗
11. 10.1016/S0169-409X(01)00242-310.1016/S0169-409X(01)00242-3 ↗
12. 10.1039/b406727d10.1039/b406727d ↗
13. Schmaljohann D. · Advanced Drug Delivery Reviews · 1655 · 58
14. 10.1007/s00396-009-2028-x10.1007/s00396-009-2028-x ↗
15. 10.1166/jbn.2015.207310.1166/jbn.2015.2073 ↗
16. 10.1039/C5TB01399B10.1039/C5TB01399B ↗
17. 10.1016/0079-6700(92)90023-R10.1016/0079-6700(92)90023-R ↗
18. 10.1021/ja065324n10.1021/ja065324n ↗
19. 10.1016/S0032-3861(97)00612-510.1016/S0032-3861(97)00612-5 ↗
20. 10.1021/ma047393x10.1021/ma047393x ↗
21. 10.1016/j.reactfunctpolym.2010.07.01510.1016/j.reactfunctpolym.2010.07.015 ↗
22. 10.1007/s00396-013-2994-x10.1007/s00396-013-2994-x ↗
23. 10.1080/1539445X.2011.59781610.1080/1539445X.2011.597816 ↗
24. 10.1021/bm300429e10.1021/bm300429e ↗
25. 10.1016/j.biomaterials.2006.08.01210.1016/j.biomaterials.2006.08.012 ↗
26. 10.1021/ma991809310.1021/ma9918093 ↗
27. 10.1080/1539445X.2011.64073110.1080/1539445X.2011.640731 ↗
28. 10.1080/00914037.2015.103064610.1080/00914037.2015.1030646 ↗
29. 10.1002/mabi.20039001410.1002/mabi.200390014 ↗
30. 10.1002/macp.20050012510.1002/macp.200500125 ↗
31. Metters A.T. · 2007
32. 10.1016/j.ijbiomac.2013.07.00210.1016/j.ijbiomac.2013.07.002 ↗
33. 10.1002/mabi.20060016410.1002/mabi.200600164 ↗
34. 10.1002/1521-3927(20020401)23:7<407::AID-MARC407>3.0.CO;2-710.1002/1521-3927(20020401)23:7<407::AID-MARC407>3.0.CO;2-7 ↗
35. 10.1002/marc.20030027910.1002/marc.200300279 ↗
36. 10.1016/S0168-3659(01)00248-610.1016/S0168-3659(01)00248-6 ↗
37. 10.1016/j.eurpolymj.2014.09.01110.1016/j.eurpolymj.2014.09.011 ↗
38. 10.1021/ma001852m10.1021/ma001852m ↗
39. 10.1021/bm060253610.1021/bm0602536 ↗
40. 10.1039/b102819g10.1039/b102819g ↗
41. 10.1080/01932691.2010.49770110.1080/01932691.2010.497701 ↗
42. 10.1016/j.msec.2012.12.03010.1016/j.msec.2012.12.030 ↗